SB

Samsara BioCapital Portfolio holdings

AUM $766M
1-Year Est. Return 329.84%
This Quarter Est. Return
1 Year Est. Return
+329.84%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$643M
AUM Growth
+$316M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
44
New
Increased
Reduced
Closed

Top Buys

1
+$95.4M
2
+$41.2M
3
+$24.6M
4
ABVX
Abivax
ABVX
+$9.1M
5
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
+$7.05M

Top Sells

1
+$11.9M
2
+$8.52M
3
+$7.94M
4
IMCR icon
Immunocore
IMCR
+$4.2M
5
EYPT icon
EyePoint Pharmaceuticals
EYPT
+$3.45M

Sector Composition

1 Healthcare 99.57%
2 Financials 0.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$2.97M 0.46%
436,813
-214,237
27
$2.87M 0.45%
196,425
28
$2.77M 0.43%
669,303
+67,100
29
$2.44M 0.38%
2,034,552
30
$1.31M 0.2%
202,348
31
$1.29M 0.2%
154,664
32
$1.18M 0.18%
52,458
33
$731K 0.11%
696,171
34
$470K 0.07%
40,888
35
$470K 0.07%
172,089
36
$393K 0.06%
689,709
37
$240K 0.04%
45,000
38
$97.7K 0.02%
78,131
39
$56K 0.01%
3,580
40
$8K ﹤0.01%
133,333
41
$1.94K ﹤0.01%
99,999
42
– –
-80,963
43
– –
-640,688
44
– –
-432,000
1
2